Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...
A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...
Many employers and insurers are scaling back coverage of Wegovy and Zepbound and a key government program, Medicare, doesn’t ...
By Grace Hussain for Sentient. Broadcast version by Shanteya Hudson for Georgia News Connection reporting for the ...
Experts say the drugs are safe and ... States could be cured with "good food." Psychiatrists and obesity experts tell ABC News that Kennedy and the Trump administration may be missing some context ...
Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...
Notice of layoffs went into effect this past weekend for employees at the Food and Drug Administration. Neither the FDA nor the Trump administration have released news about the layoffs ...
Overall, the total number of recalls under the US Food and Drug Administration and the US Department of Agriculture in 2024 ticked down compared with 2023. There was an 8% increase in recalls ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results